Reiko Inagi Univ of Tokyo - Grad. School of MedicineJapan

Prof. Reiko Inagi is a Division Chief of CKD Pathophysiology, the University of Tokyo School of Graduate Medicine. She earned her Ph.D. from Nagoya University Graduate School of Medicine, Japan, in 1990. She has researched at Osaka University School of Medicine as an assistant professor (1991-1998), moved to Tokai University School of Medicine as a lecturer. She got the “Kimoto Award” of the Japanese Society for Dialysis Therapy in 2003. Since 2008, she has been assigned to the present position. Her recent professional interests are the pathophysiological role of organelle (ER, mitochondrial, and primary cilia) stress and organelle crosstalk in kidney diseases and kidney aging. She is a councilor/secretary of the Japanese Society of Nephrology and International Maillard Reaction Society, a Steering Committee of the International Society of Nephrology, an Associate Editor of “Kidney 360” and "Physiology", an Editorial Board of “Kidney International” and “American Journal of Physiology-Renal Physiology.”

1 APRIL 2023

Time Session
08:30
10:00
Jonathan Himmelfarb Chairperson jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
Reiko Inagi Chairperson Univ of Tokyo - Grad. School of MedicineJapan
  • New Imaging Techniques in AKI
    Jennifer Charlton Speaker University of VirginiaUnited States
  • Transcriptomic Analysis of AKI
    Benjamin Humphreys Speaker Washington University in St. LouisUnited States
  • Using Stem Cells to Treat AKI
    Carol Pollock Speaker University of SydneyAustralia
  • Optogenetics in AKI
    Tsuyoshi Inoue Speaker Nagasaki UniversityJapan
  • Q and A
Plenary Halls 2 & 3
17:00
18:00
  • Acid-base and Electrolyte Abnormalities in Kidney Disease
    Andréa Stinghen Moderator Universidade Federal do ParanáBrazil
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
    Rolando Claure-Del Granado Moderator Hospital Obrero No 2 - C.N.S.Bolivia
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
    Kraiwiporn KIATTISUNTHORN Moderator Siriraj HospitalThailand
  • Chronic Kidney Disease Diagnosis, Classification and Progression 2
    Richard Kitching Moderator Monash University, Monash Medical CenterAustralia
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
    Wenjun Ju Moderator wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 3
    Hernan Trimarchi Moderator HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Covid-19 and CKD
    Opeyemi Olabisi Moderator Duke UniversityUnited States
  • Curriculum
    Prapaipim Thirakhupt Moderator prapaipimt@yahoo.com
  • Diabetic Kidney Disease, Drugs and Treatments 2
    Dr Giorgina Barbara Piccoli Moderator gpiccoli@ch-lemans.frCHM Le MansFrance
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
    Sabine Karam Moderator Saint George Hospital University Medical CenterLebanon
  • Epidemiology, Outcomes and Health Services Research in Dialysis 2
    Ana Elizabeth Figueiredo Moderator anaef@pucrs.brBrazil
  • Essential Hypertension and Renovascular Kidney Disease
    Barry Freedman Moderator Wake Forest University School of Medicine United States
  • Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
    Chairat Shayakul Moderator Faculty of Medicine Siriraj Hospital, THAILANDThailand
  • Haemodialysis, Haemodiafiltration and Vascular Access 2
    Brendan Smyth Moderator St George HospitalAustralia
  • Haemodialysis, Haemodiafiltration and Vascular Access 3
    Jonathan Himmelfarb Moderator jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
  • Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
    Youhua LIU Moderator University of PittsburghUnited States
  • Kidney Transplantation and Transplant Immunology 3
    Narayan Prasad Moderator Sanjay Gandhi Post Graduate Institute of Medical SIndia
  • Kidney Transplantation and Transplant Immunology 4
    Professor Yingyos Avihingsanon Moderator yingyos@hotmail.com
  • Late Breaking Clinical Trials
    Muh Geot Wong Moderator University of SydneyAustralia
  • Nephrotic Syndrome
    Alessia Fornoni Moderator University of MiamiUnited States
  • Other CKD 2
    Jie Dong Moderator jie.dong@bjmu.edu.cnPeking University First HospitalChina
  • Other KF (Kidney Failure)
    Tai Shuan Lai Moderator National Taiwan University HospitalTaiwan
  • Peritoneal Dialysis 2
    Piyatida Chuengsaman Moderator Thailand
  • Peritoneal Dialysis 3
    Afiatin Abdurahman Moderator
  • Training
    Naowanit Nata Moderator
  • Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
    Opas Traitanon Moderator
  • Urologic Disorders – Stones, Nephrocalcinosis
    Sritippayawan Suchai Moderator Siriraj Hospital Thailand
  • Vascular Biology and Endothelial Function
    Reiko Inagi Moderator Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall